Jianming Liu
- Cancer Research top 10%
-
- Metabolism, Diabetes, and Cancer 4
- Epigenetics and DNA Methylation 4
- Oncology top 10%
- Pharmacology top 5%
- Family Practice top 10%
-
- Epilepsy research and treatment 7
-
- Pharmacological Effects and Toxicity Studies 6
-
- Adipose Tissue and Metabolism 5
-
- Liver Disease Diagnosis and Treatment 5
- Autophagy in Disease and Therapy 4
-
- Tissue Engineering and Regenerative Medicine 4
- Journals
- Journal of Biological Chemistry (1 paper)Nature Communications (1 paper)SHILAP Revista de lepidopterología (2 papers)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Jianming Liu
73 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 123
- Cancer Research 264
- Molecular Biology 675
- Oncology 267
- Pharmacology 84
- Family Practice 21
Countries citing papers authored by Jianming Liu
This map shows the geographic impact of Jianming Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianming Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianming Liu more than expected).
Fields of papers citing papers by Jianming Liu
This network shows the impact of papers produced by Jianming Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianming Liu. The network helps show where Jianming Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jianming Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 11 | |
| 6 | 2022 | 4 | |
| 7 | 2022 | 38 | |
| 8 | 2022 | 3 | |
| 9 | 2021 | 5 | |
| 10 | 2019 | 68 | |
| 11 | 2019 | 212 | |
| 12 | 2016 | 5 | |
| 13 | 2014 | 0 | |
| 14 | 2014 | 20 | |
| 15 | 2013 | 64 | |
| 16 | 2013 | 18 | |
| 17 | 2013 | 3 | |
| 18 | 2012 | 36 | |
| 19 | 2011 | 40 | |
| 20 | 2004 | 32 |
About Jianming Liu
Jianming Liu is a scholar working on Complementary and alternative medicine, Anesthesiology and Pain Medicine and Physiology, having authored 81 papers that have together received 1.4k indexed citations. Recurring topics across this work include Epilepsy research and treatment (7 papers), Pharmacological Effects and Toxicity Studies (6 papers), Adipose Tissue and Metabolism (5 papers), Liver Disease Diagnosis and Treatment (5 papers), Tissue Engineering and Regenerative Medicine (4 papers), Metabolism, Diabetes, and Cancer (4 papers), Epigenetics and DNA Methylation (4 papers) and Autophagy in Disease and Therapy (4 papers). The work is most often cited by research in Cancer Research (264 citations), Molecular Biology (675 citations) and Oncology (267 citations). Jianming Liu has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Pinglong Xu, Rik Derynck, Masayo Sakaki‐Yumoto, Chunhua Xia, Fanglan Liu, Yi Zhou, Yang Gu, Chao Meng, Zhan‐Peng Huang and Hu Ding. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.